Engineers Gate Manager’s Pulse Biosciences PLSE Stock Holding History

Engineers Gate Manager’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,551	Closed	-$218K	–	2459
2025 Q1	$218K	Buy	+13,551	New	+$253K	﹤0.01%	1855
2024 Q4	–	Sell	-11,410	Closed	-$200K	–	2502
2024 Q3	$200K	Buy	+11,410	New	+$195K	﹤0.01%	1807

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Engineers Gate Manager's PLSE Position: Q2 2025 in Review

Engineers Gate Manager sold out of Pulse Biosciences (PLSE) in Q2 2025, closing a stake of 13,551 shares — an estimated $218K sold.

Engineers Gate Manager first reported a position in PLSE in Q3 2024 and held it in 2 quarters. The position peaked at $218K in Q1 2025. 86 funds tracked by Wall St. Rank hold PLSE as of Q2 2025.

Engineers Gate Manager reported no remaining Pulse Biosciences position as of Q2 2025 after selling out during the quarter.
Engineers Gate Manager sold 13,551 Pulse Biosciences shares in Q2 2025, an estimated $218K.
Engineers Gate Manager first reported a position in Pulse Biosciences in Q3 2024 and held it in 2 quarters.
Engineers Gate Manager's Pulse Biosciences position peaked at $218K in Q1 2025.
86 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2025.

Based on Engineers Gate Manager's 13F filing for Q2 2025, filed 14 Aug 2025.